CSE: BUX | OTCQB: BMKDF | FSE: 20B
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing
Personal Reflection: A Shared Journey of Loss and Hope My journey with BioMark Diagnostics is deeply personal. Two years ago, I lost my sister in
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity
From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented Seemingly harmless environmental factors in our homes can contribute to cancer risk.
Cancer is Rising Among Young Women: Early Detection of Lung Cancer Lung cancer rates are rising among younger women, making early detection more critical than
Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk through simple lifestyle changes! We present five actionable steps for
BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction BioMark Expands Its Liquid Biopsy Platform Receptor
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British
BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN BioMark’s Liquid Biopsy Technology Offers Promise for
